OSP
Click for more information
0.00% 20.0¢ osprey medical inc

Ann: DyeVert Clinical Data Featured at US Scientific Conferences, page-2

  1. jklotto
    539 Posts.
    lightbulb Created with Sketch. 106
    clock Created with Sketch.
    27/03/19
    11:37
    Post #: 37898331
    Osprey Medical's  DyeVert seems to be gaining some traction as more reports verify the
    reduced amount of Contrast Medium ( CM ) is reporting reduced incidents of Contrast induced
    nephropathy (CIN)...
    An article by the Journal of the American College of Cardiology dated March 4 /2019 is another
    confirmation ....

    osp study.PNG

    http://www.onlinejacc.org/content/73/9_Supplement_1/1193

    Recent increase in interest in SP may indicate a positive outcome for the upcoming 4C
    since the signing of Premier GPO back in December....imo..
    OSP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OSP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.